Pediatric Lactulose Dosing
For pediatric constipation, the recommended initial oral dose is 2.5-10 mL daily in divided doses for infants, and 40-90 mL total daily dose for older children and adolescents, with dose titration to achieve 2-3 soft stools daily 1.
Age-Specific Dosing Guidelines
Infants
- Initial dose: 2.5-10 mL daily in divided doses 1
- Adjust based on response to avoid diarrhea
- If diarrhea occurs, reduce dose immediately and discontinue if it persists
Older Children and Adolescents
- Total daily dose: 40-90 mL 1
- Divide into multiple doses throughout the day
- Titrate to produce 2-3 soft stools daily
Weight-Based Dosing from Clinical Studies
Research suggests alternative weight-based approaches:
- 1 mL/kg/day as starting dose for chronic functional constipation 2
- 500-750 mg/kg/day (approximately 0.75-1.1 mL/kg/day of standard lactulose syrup) 3
- Doses can be adjusted every 3 days based on response 2
Hepatic Encephalopathy (Specialized Use)
For the rare pediatric case requiring treatment of hepatic encephalopathy:
- Lactulose 20-30 g (30-45 mL) every 1-2 hours orally until at least 2 bowel movements occur 4
- Then titrate to maintain 2-3 soft stools daily
- Rectal administration: 300 mL lactulose mixed with 700 mL water as retention enema, retained 30-60 minutes, can repeat every 4-6 hours if needed 4, 1
Critical Dosing Considerations
Titration is essential: The goal is 2-3 soft stools daily, not maximum dosing. Excessive lactulose causes complications including dehydration, hypernatremia, aspiration risk, and severe perianal irritation 5.
Common pitfall: Escalating doses excessively when initial doses fail. Lack of response should prompt evaluation for other causes rather than aggressive dose increases 5.
Compliance issues: Studies show lactulose has more side effects (abdominal pain, flatus) compared to alternatives, affecting adherence, particularly after 4 weeks of therapy 2, 3. Consider this when planning long-term management.
Comparative Efficacy Notes
While the FDA label provides official dosing 1, clinical studies suggest:
- Liquid paraffin may be more effective with fewer side effects than lactulose in pediatric constipation 2
- PEG 3350 shows superior efficacy with better tolerability 6
- Lactulose remains widely used due to availability and cost, but consider alternatives if side effects limit compliance
Weaning consideration: When discontinuing after successful treatment (>3 months), gradual reduction over 3 months shows low success rates regardless of method, with pre-weaning doses >1.5 g/kg/day associated with better outcomes 7. This highlights the need for prolonged maintenance therapy in many children.